⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 19, 2024Frontiers in OncologyOpen Access

Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy

José Luís Piñana Lourdes Vázquez Inmaculada Heras Tommaso Francesco Aiello Lucía López‐Corral Ignacio Arroyo Eva Soler‐Espejo Irene García‐Cadenas Valentín García‐Gutiérrez Cristina Aroca Pedro Chorão María Teresa Olave Javier López‐Jiménez Marina Acera Gómez Elena Arellano Marian Cuesta-Casas Alejandro Avendaño-Pita Clara González-Santillana José‐Ángel Hernández‐Rivas Alicia Roldán Mireia Micó-Cerdà Manuel Guerreiro Julia Morell Paula Rodriguez-Galvez Jorge Labrador Diana Campos Ángel Cedillo Carolina García‐Vidal Rodrigo Martino Carlos Solano

View Full Paper

Ask AI

Bookmark

Share

Abstract

Scarce real-life data exists for COVID-19 management in hematologic disease (HD) patients in the Omicron era.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Piñana et al. (2024) studied this question.

synapsesocial.com/papers/68e64178b6db6435875d2ae5 https://doi.org/10.3389/fonc.2024.1389345

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Chinese expert consensus on the management of patients with hematologic malignancies infected with SARS-CoV-2Original Research · 2023 · 5 citations
2Basic therapeutic approaches to the management of hematology/oncology patients with new coronavirus infection (COVID-19)Clinical Trial · 2024 · 1 citations
3Extended remdesivir administration in haematological patients with malignancies and COVID-19 during the Omicron era: safety and outcomes2024 · 4 citations
4Severe acute respiratory syndrome coronavirus 2 infection in patients with hematological malignancies in the Omicron era: Respiratory failure, need for mechanical ventilation and mortality in seronegative and seropositive patients2024 · 3 citations
5COVID-19 in Patients with Different Hematological Malignancies: Treatment Strategy and Outcome: An Iraqi Experience2024

More related papers

COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches2024
Hematological Conditions Associated with COVID-19: Pathophysiology, Clinical Manifestations, and Therapeutic Approaches2024
Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies2024

More from Frontiers in Oncology

Case Report: A case of early rapid recurrence of a primary intracranial alveolar soft part sarcoma with high proliferative activity and complex molecular variationsThu,
Targeting the MLN64/STARD3-cholesterol axis disrupts tight junction remodelling and attenuates gastric cancer aggressivenessThu,